The authors show that the treatment of autologous CD4 + CD40 / IL-4 T lymphocytes with CLL-EVs derived from miR-363 knockdown cells blocked the modulation of T-cell migration speed [31]. This evidence concerns the gene IL4 and B-cell chronic lymphocytic leukemia.